mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.084 |
0.03 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.066 |
0.03 |
mRNA |
COL-3 |
CTRPv2 |
pan-cancer |
AAC |
0.082 |
0.03 |
mRNA |
AZD6482 |
GDSC1000 |
pan-cancer |
AAC |
-0.071 |
0.03 |
mRNA |
CHEMBL374350 |
CTRPv2 |
pan-cancer |
AAC |
0.083 |
0.03 |
mRNA |
OSI-906 |
CTRPv2 |
pan-cancer |
AAC |
0.077 |
0.03 |
mRNA |
VX-702 |
GDSC1000 |
pan-cancer |
AAC |
0.077 |
0.03 |
mRNA |
Nilotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.08 |
0.03 |
mRNA |
ABT-199 |
CTRPv2 |
pan-cancer |
AAC |
-0.095 |
0.03 |
mRNA |
SID 26681509 |
CTRPv2 |
pan-cancer |
AAC |
-0.082 |
0.03 |